BioMarin Pharmaceutical Inc.
GB ˙ LSE ˙ US09061G1013
57,62 $ ↑1,19 (2,11%)
2026-06-05
DEL PRIS
SecurityGB:0HNC / BioMarin Pharmaceutical Inc.
InstitutionTwo Sigma Securities, Llc
Latest Disclosed Ownership22,096 shares
Latest Disclosed Value $ 1,248,203
Two Sigma Securities, Llc ownership in 0HNC / BioMarin Pharmaceutical Inc.

On May 15, 2026 - Two Sigma Securities, Llc filed a 13F-HR form disclosing ownership of 22,096 shares of BioMarin Pharmaceutical Inc. (GB:0HNC) valued at $1,230,747 USD as of March 31, 2026. The entity filed a previous 13F-HR on November 14, 2025 disclosing 0 shares of BioMarin Pharmaceutical Inc.. The current value of the position is $1,273,172 USD.

Two Sigma Securities, Llc has a history of taking positions in derivatives of the underlying security (0HNC) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

GB:0HNC / BioMarin Pharmaceutical Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 22,096 22,096 1,248 0.1450
2025-11-14 2025-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -29,512 -100.00 0 -100.00
2025-08-14 2025-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 29,512 29,512 1,622 0.2001
2025-05-15 2025-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -3,284 -100.00 0 -100.00
2025-02-14 2024-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 3,284 -100,143 -96.82 216 -97.04 0.0286
2024-11-14 2024-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 103,427 74,598 258.76 7,270 206.32 0.1227
2024-08-14 2024-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 28,829 -8,843 -23.47 2,373 -27.87 0.0287
2024-05-15 2024-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 37,672 17,364 85.50 3,290 68.03 0.0318
2024-02-14 2023-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 20,308 12,552 161.84 1,958 185.42 0.0189
2023-11-14 2023-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 7,756 -3,971 -33.86 686 -32.48 0.0073
2023-08-14 2023-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 11,727 11,727 1,016 0.0151
2022-11-14 2022-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -8,803 -100.00 0 -100.00
2022-08-15 2022-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 8,803 8,803 730 0.0259
2021-11-15 2021-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -3,350 -100.00 0 -100.00
2021-08-16 2021-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 3,350 -15,950 -82.64 280 -88.24 0.0084
2020-08-14 2020-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 19,300 19,300 476.12 2,380 750.00 0.0534
2020-05-15 2020-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -20,905 -100.00 0 -100.00
2020-02-14 2019-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 20,905 20,905 1,768 0.0119
2019-05-15 2019-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -4,154 -100.00 0 -100.00
2019-02-14 2018-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 4,154 -6,443 -60.80 354 -65.56 0.0043
2018-11-14 2018-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 10,597 -19,968 -65.33 1,028 -64.29 0.0067
2018-08-14 2018-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 30,565 14,623 91.73 2,879 122.83 0.0143
2018-05-15 2018-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 15,942 12,698 391.43 1,292 347.06 0.0072
2018-02-14 2017-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 3,244 3,244 -79.65 289 -77.63 0.0077
2017-11-14 2017-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -10,786 -100.00 0 -100.00
2017-08-14 2017-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 10,786 10,786 980 0.1865
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-05-15 2025-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-02-14 2024-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 3,600 -60.44 237 -63.07 n/a n/a n/a
2024-11-14 2024-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 9,100 -13.33 640 -26.04 n/a n/a n/a
2024-08-14 2024-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 10,500 864 n/a n/a n/a
2021-05-17 2021-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-16 2020-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 8,800 772 n/a n/a n/a
2020-11-16 2020-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-09-10 2020-06-30 13F/A BIOMARIN PHARMACEUTICAL COM Call 13,800 150.91 1,702 266.02 n/a n/a n/a
2020-05-15 2020-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 5,500 -35.29 465 -35.33 n/a n/a n/a
2020-02-14 2019-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 8,500 25.00 719 56.99 n/a n/a n/a
2019-11-14 2019-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 6,800 15.25 458 -9.31 n/a n/a n/a
2019-08-14 2019-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 5,900 96.67 505 89.85 n/a n/a n/a
2019-05-15 2019-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 3,000 -49.15 266 -47.33 n/a n/a n/a
2019-02-14 2018-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-11-14 2018-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 2,100 -46.15 204 -44.41 n/a n/a n/a
2018-08-14 2018-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 3,900 -58.95 367 -52.34 n/a n/a n/a
2018-05-15 2018-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 9,500 111.11 770 92.02 n/a n/a n/a
2018-02-14 2017-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 4,500 401 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-02-14 2024-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-11-14 2024-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 3,200 -75.19 225 -78.91 n/a n/a n/a
2024-08-14 2024-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 12,900 148.08 1,062 133.92 n/a n/a n/a
2024-05-15 2024-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 5,200 100.00 454 81.60 n/a n/a n/a
2024-02-14 2023-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 2,600 251 n/a n/a n/a
2021-11-15 2021-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-08-16 2021-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 2,700 225 n/a n/a n/a
2021-05-17 2021-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-16 2020-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 3,900 -9.30 342 4.59 n/a n/a n/a
2020-11-16 2020-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 4,300 -21.82 327 -51.77 n/a n/a n/a
2020-09-10 2020-06-30 13F/A BIOMARIN PHARMACEUTICAL COM Put 5,500 129.17 678 233.99 n/a n/a n/a
2020-05-15 2020-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 2,400 -89.09 203 -89.09 n/a n/a n/a
2020-02-14 2019-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 22,000 378.26 1,860 500.00 n/a n/a n/a
2019-11-14 2019-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 4,600 -55.34 310 -64.85 n/a n/a n/a
2019-08-14 2019-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 10,300 58.46 882 52.86 n/a n/a n/a
2019-05-15 2019-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 6,500 91.18 577 98.97 n/a n/a n/a
2019-02-14 2018-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 3,400 -75.89 290 -78.79 n/a n/a n/a
2018-11-14 2018-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 14,100 -67.59 1,367 -66.64 n/a n/a n/a
2018-08-14 2018-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 43,500 42.16 4,098 65.18 n/a n/a n/a
2018-05-15 2018-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 30,600 2,481 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.